1. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Issue 10093 (29th July 2017) Authors: Kanes, Stephen; Colquhoun, Helen; Gunduz-Bruce, Handan; Raines, Shane; Arnold, Ryan; Schacterle, Amy; Doherty, James; Epperson, C Neill; Deligiannidis, Kristina M; Riesenberg, Robert; Hoffmann, Ethan; Rubinow, David; Jonas, Jeffrey; Paul, Steven; Meltzer-Brody, Samantha Journal: Lancet Issue: Volume 390:Issue 10093(2017) Page Start: 480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brexanolone as adjunctive therapy in super‐refractory status epilepticus. Issue 3 (11th September 2017) Authors: Rosenthal, Eric S.; Claassen, Jan; Wainwright, Mark S.; Husain, Aatif M.; Vaitkevicius, Henrikas; Raines, Shane; Hoffmann, Ethan; Colquhoun, Helen; Doherty, James J.; Kanes, Stephen J. Journal: Annals of neurology Issue: Volume 82:Issue 3(2017) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Issue 10152 (22nd September 2018) Authors: Meltzer-Brody, Samantha; Colquhoun, Helen; Riesenberg, Robert; Epperson, C Neill; Deligiannidis, Kristina M; Rubinow, David R; Li, Haihong; Sankoh, Abdul J; Clemson, Christine; Schacterle, Amy; Jonas, Jeffrey; Kanes, Stephen Journal: Lancet Issue: Volume 392:Issue 10152(2018) Page Start: 1058 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Insights on GABAergic Mechanism of PPD from Pivotal Studies of Brexanolone Injection and SAGE-217 [18E]. (May 2020) Authors: Meltzer-Brody, Samantha; Deligiannidis, Kristina; Colquhoun, Helen; Gunduz-Bruce, Handan; Dray, Danielle; Kanes, Stephen Journal: Obstetrics and gynecology Issue: Volume 135(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression. (March 2017) Authors: Kanes, Stephen J.; Colquhoun, Helen; Doherty, James; Raines, Shane; Hoffmann, Ethan; Rubinow, David R.; Meltzer‐Brody, Samantha Journal: Human psychopharmacology Issue: Volume 32:Number 2(2017:Mar.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase 3 Study Evaluating Brexanolone, a GABAA Receptor Modulator, in Moderate Postpartum Depression [25H]. (May 2018) Authors: Kanes, Stephen; Colquhoun, Helen; Riesenberg, Robert; Rubinow, David; Maximos, Bassem; Meltzer-Brody, Samantha Journal: Obstetrics and gynecology Issue: Volume 131(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase 3 Study Evaluating Brexanolone, a GABAA Receptor Modulator, in Severe Postpartum Depression [29B]. (May 2018) Authors: Meltzer-Brody, Samantha; Kanes, Stephen; Riesenberg, Robert; Rubinow, David; Maximos, Bassem; Colquhoun, Helen Journal: Obstetrics and gynecology Issue: Volume 131(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗